Interleukin 2 News and Research

RSS
Blocking IL-11 signaling can promote liver regeneration after paracetamol-induced damage

Blocking IL-11 signaling can promote liver regeneration after paracetamol-induced damage

Baseline use of DMARDs linked with COVID-19 severity in rheumatoid arthritis patients

Baseline use of DMARDs linked with COVID-19 severity in rheumatoid arthritis patients

Could a fungus-derived compound reduce hyperinflammation in severe COVID-19?

Could a fungus-derived compound reduce hyperinflammation in severe COVID-19?

Protein found in mice’s immune system could protect babies from necrotizing enterocolitis

Protein found in mice’s immune system could protect babies from necrotizing enterocolitis

Cinnamon compound could be useful supplement to dexamethasone in COVID-19 treatment

Cinnamon compound could be useful supplement to dexamethasone in COVID-19 treatment

The role of natural killer cells in fight against viral infections including SARS-CoV-2

The role of natural killer cells in fight against viral infections including SARS-CoV-2

SARS-CoV-2 oral vaccine booster shows promise in animal tests

SARS-CoV-2 oral vaccine booster shows promise in animal tests

Potent antibodies against SARS-CoV-2 can be produced without T follicular helper cells, suggests study

Potent antibodies against SARS-CoV-2 can be produced without T follicular helper cells, suggests study

Immune memory responses differ between SARS-CoV-2 and influenza A

Immune memory responses differ between SARS-CoV-2 and influenza A

Forkhead box O's potential therapeutic use in the treatment of COVID-19

Forkhead box O's potential therapeutic use in the treatment of COVID-19

Humoral innate pattern recognition molecules against SARS-CoV-2

Humoral innate pattern recognition molecules against SARS-CoV-2

Are women more likely to develop long COVID?

Are women more likely to develop long COVID?

Natural products show promise against COVID-19 via iron chelation

Natural products show promise against COVID-19 via iron chelation

Could sustained inflammation following mild to moderate COVID-19 be a driver of long COVID?

Could sustained inflammation following mild to moderate COVID-19 be a driver of long COVID?

High baseline levels of inflammatory cytokines linked to thrombotic events in patients with COVID-19

High baseline levels of inflammatory cytokines linked to thrombotic events in patients with COVID-19

Metformin potently inhibits SARS-CoV-2-induced cytokine release in monocytes

Metformin potently inhibits SARS-CoV-2-induced cytokine release in monocytes

Maternal SARS-CoV-2 infection imprints immune response in the newborn

Maternal SARS-CoV-2 infection imprints immune response in the newborn

Hydroxychloroquine + Azithromycin therapy at a higher dose improved survival by nearly 200% in ventilated COVID patients

Hydroxychloroquine + Azithromycin therapy at a higher dose improved survival by nearly 200% in ventilated COVID patients

E484K mutation may confer immune evasion capability on UK variant of SARS-CoV-2

E484K mutation may confer immune evasion capability on UK variant of SARS-CoV-2

Large-scale expansion of spike-reactive T cells feasible after COVID-19 vaccination

Large-scale expansion of spike-reactive T cells feasible after COVID-19 vaccination